Algernon Pharmaceuticals Inc. C.AGN

Upcoming Work

[SkywalkerofLuke]

AGN.c AGNPF is currently undergoing clinical studies and the results could be a major catalyst if they’re successful.

Some of their upcoming work includes

- Have a 180 patient, 90-day Phase 2b clinical study of Ifenprodil for chronic cough that will begin in Q3

- Planning to be the first company globally to investigate DMT for TBI (traumatic brain injury) in humans and are working towards a Phase 2 clinical trial in Q4

https://ir.algernonpharmaceuticals.com/news-events/press-releases

[Whalewatcher1]

So how will these clinical trials be finding when the company has over $2M in payables and no Cdh based on financial statements. They are doing a rights offering that likely won't even cover the payables.  if assume $80k per patient for chronic couch, where does the $14M plus come from? same question for TBI, who is going to fund? Your email is very misleading as this company

[Whalewatcher1]

And don't forget these guys are more interested in promoting the stock by using cash on marketing and not drug development. Someone should tell them that marketing comes after approval hahah